易明医药：第三季度净利润同比增长1934%

Core Insights - The company reported a third-quarter revenue of 178 million, representing a year-on-year increase of 10.37% [1] - The net profit for the third quarter was 44.21 million, showing a significant year-on-year growth of 1934.12% [1] - For the first three quarters, the total revenue was 489 million, reflecting a year-on-year decline of 4.65% [1] - The net profit for the first three quarters reached 81.76 million, which is a year-on-year increase of 95.52% [1]